Central glutamate signaling in postoperative pain regulation - Renewal
术后疼痛调节中的中枢谷氨酸信号 - 更新
基本信息
- 批准号:10450749
- 负责人:
- 金额:$ 46.61万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-08-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsAcuteAddressAffectiveAnalgesicsAnimalsAnteriorBehaviorBrainBrain regionChronicDataDevelopmentDoseElectric StimulationElectrophysiology (science)EnhancersEpidemicFDA approvedFundingGlutamatesGoalsHumanHyperactivityIn VitroKetamineLeadLiteratureMachine LearningMental DepressionMethodsModelingModificationMorbidity - disease rateN-Methyl-D-Aspartate ReceptorsNervous system structureNeuronsNeurosciencesOperative Surgical ProceduresOrganismOutputPainPain ClinicsPharmaceutical PreparationsPharmacologyPhysiologicalPhysiologyPostoperative PainPostoperative PeriodPre-Clinical ModelPrefrontal CortexProcessProtocols documentationPublishingRattusRegimenRegulationResearchResolutionRodentRoleSensoryShapesSignal TransductionSliceSurgical incisionsSymptomsSynapsesSystemTechniquesTestingTherapeuticWorkaddictionallodyniaantagonistawakebasecentral painchronic paincingulate cortexcombatdesigndrug testingextracellularglutamatergic signalingimprovedin vivoinnovationnerve damagenerve injuryneuropsychiatryneuroregulationnociceptive responsenon-opioid analgesicnovelnovel therapeuticsopioid epidemicopioid useoptogeneticspain behaviorpain inhibitionpain modelpain reductionpain reliefrelating to nervous systemresponsespared nervesupervised learningsynergismtherapeutic evaluationtherapeutic target
项目摘要
Postoperative pain is a major morbidity, and persistent opioid use after surgery has contributed to an epidemic.
An improved mechanistic understanding of how pain is regulated within the brain can lead to novel non-opioid
analgesic development. The long-term goal of this proposal is to understand the central regulation of
postoperative pain. The objective of the current application is to define the role of prelimbic cortex (PL) and
anterior cingulate cortex (ACC), two key components of the prefrontal cortex in rodents, in the regulation of acute
and chronic postoperative pain. The PL is homologous to human dorsolateral prefrontal cortex that is known to
undergo synaptic changes with chronic pain, and the ACC is a well-described region for processing affective
component of pain across species. Our central hypothesis is that an imbalance in neural activities in the PL and
ACC contributes to symptoms of postoperative pain and thus forms a therapeutic target. Our hypothesis is
supported by the current literature showing that the PL has a pain-inhibitory role, whereas the ACC enhances
pain aversion, and that chronic pain causes increased excitability in the ACC and hypo-excitability in the PL. It
is also supported by our recent results demonstrating that AMPAkines and ketamine, drugs that alter glutamate
signaling and shape cortical circuits, reduce pain. In Aim 1, we will test the hypothesis that an imbalance in ACC
and PL activities contributes to postoperative pain in awake freely behaving rats. We will use paw incision (PI)
to mimic acute reversible incisional pain, and spared nerve injury (SNI) to model chronic pain after intraoperative
nerve damage. We will first correlate imbalanced prefrontal activities with pain, by showing a concurrent loss of
nociceptive response in the PL and gain of response in the ACC as pain behavior persists, and the resolution of
such neural changes as pain resolves, using simultaneous in vivo extracellular recordings of the PL and ACC.
Further, to test the causal effect of this imbalance on pain, we will show that optogenetic PL activation, or ACC
inhibition, reverses postoperative pain behaviors. Next, we will use optrode recordings to dissect a local pain-
regulatory circuit fromthe PL to the ACC. Further, we will use an unbiased supervised machine learning analysis
to validate the relationship between the imbalance in PL and ACC activities and the chronicity of postoperative
pain. In Aim 2, We will test the hypothesis that pharmacologic and electrical neuromodulation can target
imbalanced PL/ACC activities in the postoperative pain state. We will show that AMPAkines and ketamine
increase PL outputs and reduce ACC activities to inhibit pain and optimize the timing and dosing regimens for
these drugs and test therapeutic synergy. We will also optimize invasive and non-invasive electrical stimulation
protocols in the PL to treat pain. This project is innovative because it applies a new systems neuroscience
approach with cutting-edge techniques to uncover a central pain-regulatory mechanism. The work is significant
because it produces novel applications of FDA-approved drugs (ketamine and APMAkines) for postoperative
pain and a blueprint for new deep brain or transcranial stimulation methods to treat pain.
术后疼痛是一个主要的发病率,术后持续使用阿片类药物导致了一种流行病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jing Wang其他文献
Electrochemical performance of high-capacity nanostructured Li[Li0.2Mn0.54Ni0.13Co0.13]O2 cathode material for lithium ion battery by hydrothermal method
水热法制备锂离子电池高容量纳米结构Li[Li0.2Mn0.54Ni0.13Co0.13]O2正极材料的电化学性能
- DOI:
10.1016/j.electacta.2013.05.118 - 发表时间:
2013-09 - 期刊:
- 影响因子:6.6
- 作者:
Xin Wei;Shichao Zhang;Zhijia Du;Puheng Yang;Jing Wang;Yanbiao Ren - 通讯作者:
Yanbiao Ren
Jing Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jing Wang', 18)}}的其他基金
Targeting Sigma 1 receptor as a novel therapy for limiting neurovascular injury in ROP
靶向 Sigma 1 受体作为限制 ROP 神经血管损伤的新疗法
- 批准号:
10718424 - 财政年份:2023
- 资助金额:
$ 46.61万 - 项目类别:
Optimizing coordinated reset deep brain stimulation for Parkinson's disease
优化帕金森病的协调重置深部脑刺激
- 批准号:
10267675 - 财政年份:2020
- 资助金额:
$ 46.61万 - 项目类别:
Optimizing coordinated reset deep brain stimulation for Parkinson's disease
优化帕金森病的协调重置深部脑刺激
- 批准号:
10636865 - 财政年份:2020
- 资助金额:
$ 46.61万 - 项目类别:
Optimizing coordinated reset deep brain stimulation for Parkinson's disease
优化帕金森病的协调重置深部脑刺激
- 批准号:
10413216 - 财政年份:2020
- 资助金额:
$ 46.61万 - 项目类别:
Optimizing coordinated reset deep brain stimulation for Parkinson's disease
优化帕金森病的协调重置深部脑刺激
- 批准号:
10030344 - 财政年份:2020
- 资助金额:
$ 46.61万 - 项目类别:
Targeting TGFbeta/PDK4 to Overcome Drug Resistance in Colorectal Cancer
靶向 TGFbeta/PDK4 克服结直肠癌耐药性
- 批准号:
10000912 - 财政年份:2018
- 资助金额:
$ 46.61万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 46.61万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 46.61万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 46.61万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 46.61万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 46.61万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 46.61万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 46.61万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 46.61万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 46.61万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 46.61万 - 项目类别:
Operating Grants